Aetna International appoints new CEO for EMEA region

By Sophie Chapman
Following the decision to merge its European and Middle East, and Africa divisions, Aetna International – a health insurance company – have appointe...

Following the decision to merge its European and Middle East, and Africa divisions, Aetna International – a health insurance company – have appointed a new CEO to the newly create EMEA region.

David Healy joined the company in 2012 and became General Manager for the Europe Division, as well as the Vice President Head of Global Operations.

Aetna International have more than 900,000 members across the world, and Healy will be responsible for expanding international business, offering health benefits and health management solutions.

The CEO will have a team of more than 500 individuals within EMEA and will be responsible for working with the region’s strategic partners, governments, and health officials.

SEE ALSO:

Healy has more than 30 years of experience working with International Insurance and Employee Benefits Industries.

“In order to support our strategy to scale-up our capabilities, work with stakeholders on further developing healthcare infrastructure and create greater access to the right healthcare solutions, we have implemented a new structure by creating an EMEA region,” stated Mr Healy.

“Not only will this allow us to leverage our strengths and give our people the best environment to contribute and develop, it will also allow faster decision-making, more regional empowerment and accountability and put our customer groups at the heart of everything we do – including brokers.”

Prior to his current role, Healy worked for AEGON Ireland as Managing Director for life.

Share

Featured Articles

UnitedHealth CEO Admits Hack hit Third of US Citizens' Data

UnitedHealth Group CEO Andrew Witty tells stunned US congressional hearing Change Healthcare cyberattack affects third of the US population

Why Sanofi Leads the way on Healthcare Sustainability

How French multinational Sanofi is ensuring delivery of essential medical supplies while being ESG-compliant

Philips Q1 Results hit by $1.1bn Respironics Settlement

As Royal Philips reports Q1 2024 results we profile the Netherlands-based healthcare technology company, who made the switch from consumer electronics

Vaccine Breakthrough on Antibiotics Resistant Diseases

Medical Devices & Pharma

Oracle Fusion Cloud Update Boost for Patients

Technology & AI

WHO Tightens air Quality Guidelines as Pollution Kills 7mn

Sustainability